2897. Collocated Buprenorphine Is Associated with Improved HCV Visit Adherence in People Who Inject Drugs (PWID): Data From the ANCHOR Study

BACKGROUND: Engaging PWID in HCV treatment and monitoring for reinfection is critical to eliminate HCV and improve health in people who use drugs. However, PWID are often marginalized and can be difficult to engage and retain in care. The collocation of HCV treatment with buprenorphine to treat opio...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenthal, Elana S, Silk, Rachel, Mathur, Poonam, Eyasu, Rahwa, Nussdorf, Laura, Hill, Kristi, D’Amore, Aaron, Brokus, Christopher, Bijole, Phyllis, Jones, Miriam, Kier, Randy, Sternberg, David, Masur, Henry, Kottilil, Shyam, Kattakuzhy, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808822/
http://dx.doi.org/10.1093/ofid/ofz359.175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808822/
http://dx.doi.org/10.1093/ofid/ofz359.175

Ejemplares similares